Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Acro Biomedical's operating cash flow for the twelve months ending Jun 30, 2026 was -$140.11K. For fiscal 2025 it was -$196.30K. The highest annual figure on record is $299.34K in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$196.30K | – |
| FY2024 | Dec 31, 2024 | -$36.69K | – |
| FY2023 | Dec 31, 2023 | -$15.45K | – |
| FY2022 | Dec 31, 2022 | -$147.48K | -149.3% |
| FY2021 | Dec 31, 2021 | $299.34K | +275.6% |
| FY2019 | Sep 30, 2019 | $79.69K | – |
| FY2018 | Sep 30, 2018 | -$140.42K | – |
| FY2017 | Sep 30, 2017 | -$463.34K | – |
| FY2016 | Sep 30, 2016 | -$34.74K | – |
| FY2015 | Sep 30, 2015 | -$48.85K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$10.50K | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$49.82K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$25.38K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$54.41K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$93.98K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$22.53K | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$10.52K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$6.34K | -1411.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$6.33K | -381.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$13.51K | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$12.61K | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $483 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $2.25K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$5.57K | -102.1% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$10.57K | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$53.27K | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$345.78K | -179.9% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $262.13K | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$60.51K | -241.1% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$64.55K | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $432.77K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$8.38K | -104.8% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $42.87K | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$85.18K | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$52.34K | -112.8% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $174.33K | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$4.17K | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$512.36K | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $409.37K | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$33.26K | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$416.18K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$17.55K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$29.47K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$142 | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$9.61K | – |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | -$5.60K | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | -$8.17K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | -$11.37K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | -$1.52K | – |
| Q3 FY2015CQ2 2015 | Jun 30, 2015 | -$2.20K | – |
See a number that looks wrong?